Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	185.84	1653.17	-578.37
Graham Fair Price	-40.97	1.69	2.87
PEG	200.66	-2.80	0.93
Price/Book	-29.09	4.10	5.79
Price/Cash Flow	92.26	-35.02	-452.24
Prices/Earnings	104.56	376.67	-184.14
Price/Sales	-12.62	10.85	12.42
Price/FCF	92.26	-35.02	-452.24
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	6.39	0.21	0.20
Operating Margin	85.97	< 0.005	-0.03
ROA	-63.99	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-65.34
ROIC	< 0.005	< 0.005	-75.28
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.43	< 0.005	15673.55
Dividends QOQ	-0.48	0.78	61.95
EBIT QOQ	-2.28	0.89	-61.14
EPS QOQ	-1.98	1.35	-31.97
FCF QOQ	0.67	-8.18	1122.96
Revenue QOQ	-0.03	-0.19	-492.33
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	96.68	150.54	55.71
Days Sales Outstanding (DSO)	159.79	149.20	-6.63
Inventory Turnover	0.93	0.60	-35.78
Debt/Capitalization	0.29	0.36	24.55
Quick Ratio	1.03	0.84	-18.54
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.82	6.84	0.26
Cash	1.83	1.29	-29.84
Capex	-0.54	-0.51	6.77
Free Cash Flow	-0.09	-0.80	-817.94
Revenue	3.18	2.59	-18.64
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.44	1.40	-3.38
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-21.54	167.16	676.14
Naive Interpretation	Member

06 - Financial Health · Weak

Rating